期刊文献+

淋巴结内外弥漫大B细胞性淋巴瘤分化特征分析

暂未订购
导出
摘要 目的探讨淋巴结内、外弥漫性大B细胞性淋巴瘤(DLBCL)的分化特点。方法收集108例DLBCL的临床病理资料,结内56例,结外52例,应用免疫组织化学方法检测CD10、Bcl-6、Mum-1和LMP-1的表达,对淋巴结内、外DLBCL瘤细胞分化特征及与EBV的关系进行分析。结果结内组以生发中心型(GCB)分化多见,GCB-DLBCL和非GCB-DLBCL分别占60.7%和39.3%;结外组以非GCB分化多见,GCB-DLBCL和非GCB-DLBCL分别占40.4%和59.6%,两者差异有统计学意义(P<0.05);临床分期Ⅲ~Ⅳ期者共59例,其中结内组29例,结外组30例,其临床分期与结内、外及GCB和非GCB分化无关(P>0.05)。108例DLBCL无一例表达LMP-1蛋白。结论淋巴结DLBCL分化方向以GCB型多见,而结外DLBCL分化方向以非GCB型多见;淋巴结内外DLBCL均无LMP-1表达。
出处 《广东医学》 CAS CSCD 北大核心 2011年第16期2183-2185,共3页 Guangdong Medical Journal
基金 海南省自然科学基金资助项目(编号:309037)
  • 相关文献

参考文献10

  • 1JAFFE E S, HARRIS N L, STEIN H, et al. WHO classification of tumor: pathology and genetics of tumors of haematopoietic and lymphoid tissues[ M]. Lyon: IARC Press, 2001 : 171.
  • 2SWERDLOW S H, CAMPO E, HARRIS N L, et al. WHO classification of tumors of haematopoietic and lymphoid tissues [ M ]. Lyon: IARC Press, 2008 : 267 - 368.
  • 3ALIZADEH A A, EISEN M B, DAVIS R E, et al. Distinct types of diffuse large B - cell lymphoma identified by gene expression profiling[J]. Nature, 2000, 403(6769): 503 -511.
  • 4CHANG C C, MCCLINTOCK S, CLEVELAND R P, et al. Immunohistochemical expression patterns of germinal center and activa- tion B - cell markers correlate with prognosis in diffuse large B - cell lymphoma[ J~. Am J Surg Pathol, 2004, 8(4) : 464 -470.
  • 5HANS C P, WEISENBURGER D D, GREINER T C, et al. Con- firrnation of the molecular classification of diffuse large B - cell lymphoma by immunohistochemistry using a tissue microarray[ J]. Blood, 2004, 103 (1):275-282.
  • 6STEVEN H, ELIAS C, NANCY L H, et al. WHO classification of tumors: pathology and genetics of tumors of haematopoietic and lymphoid tissues[ M]. Lyon: IARC Press, 2008:233-244.
  • 7陆锦标,李小秋,张培红,周晓燕,张太明,李小妹,朱雄增.结内外弥漫性大B细胞淋巴瘤的免疫表型和分化特征及预后的比较[J].中华病理学杂志,2007,36(7):470-473. 被引量:10
  • 8DE LEVAL L, HARRIS N L. Variability in immunophenotype in diffuse large B - cell lymphoma and its clinical relevance[ J]. Histopathology, 2003, 43 (6) : 509 - 528.
  • 9DOGAN A, BAGDI E, MUNSON P, et al. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B - cell lymphomas[J]. Am J Surg Pathol, 2000, 24(6) : 846 -852.
  • 10LENBURG M E, SINHA A, FALLER D V, et al. Tumor specific and proliferation specific gene expression typifies murine transgenic B cell lymphomagenesis[ J]. J Biol Chem, 2007, 282(7): 4803 - 4811.

二级参考文献8

  • 1Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-Bcell lymphoma. N Engl J Med, 2002, 346(25) :1937-1947.
  • 2Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 2004, 103( 1 ) :275-282.
  • 3Kramer MH, Hermans J, Wijburg E, et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood, 1998, 92(9) :3152-3162.
  • 4Camilleri-Broet S, Criniere E, Broet P, et al. A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary cenlral nervous system lymphoma: analysis of 83 cases. Blood, 2005, 107( 1 ) : 190-196.
  • 5Yoshida S, Nakamura N, Sasaki Y, et al. Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype. Mod Pathol, 2005, 18(3 ) : 398-405.
  • 6Lopez-Guillermo A, Colomo L, Jimenez M, et al. Diffuse large Bcell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol, 2005,23(12) :2797-2804.
  • 7Berglund M, Thunberg U, Amini RM, et al. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis. Mod Pathol, 2005, 18(8) :1113-1120.
  • 8Muffs J, Meijer C, Vos W, et al. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk slratification in patients with primary nodal diffuse large B cell lymphoma. J Pathol, 2006, 208(5) :714-723.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部